{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:22:12Z","timestamp":1778998932237,"version":"3.51.4"},"reference-count":11,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J STD AIDS"],"published-print":{"date-parts":[[2010,2]]},"abstract":"<jats:p> The aim of the present study is to investigate the rate of co-infections with other sexually transmitted infections (STIs), antibiotic susceptibility and management of oropharyngeal gonorrhoea diagnosed in a busy genitourinary medicine clinic. The method involved a retrospective study on consecutive patients diagnosed with oropharyngeal gonorrhoea. A total of 131 patients were diagnosed with oropharyngeal gonorrhoea over the study period. The median age of the infected patients was 28 (interquartile range: 22 to 35) years. Forty-one (31%) of patients were younger than 24 years. High rates of co-infection with urethral gonorrhoea (37%), rectal gonorrhoea (37%) or chlamydial infection (16%) were identified. Thirty patients (23%) had only oropharyngeal infection. Twenty-two (17%) patients' isolates showed resistance to at least one antibiotic. Antibiotic resistance among oropharyngeal gonococcal isolates was above 5% between 2000 and 2009. Test-of-cure (TOC) was carried out for only 63 (48%) of patients; none had positive culture. Among 46 isolates treated with cefixime 400 mg\/stat, 27 (59%) had TOC; all were negative. Repeat TOC was not carried out for any of the patients. In conclusion, successful management of oropharyngeal gonorrhoea should comprise of counselling, partner notification and TOC after treatment with appropriate antibiotic regimen. <\/jats:p>","DOI":"10.1258\/ijsa.2009.009167","type":"journal-article","created":{"date-parts":[[2009,11,3]],"date-time":"2009-11-03T03:04:47Z","timestamp":1257217487000},"page":"138-140","source":"Crossref","is-referenced-by-count":13,"title":["Oropharyngeal gonorrhoea: rate of co-infection with sexually transmitted infection, antibiotic susceptibility and treatment outcome"],"prefix":"10.1177","volume":"21","author":[{"given":"K","family":"Manavi","sequence":"first","affiliation":[{"name":"Department of Genitourinary Medicine, Whittall Street Clinic, Whittall Street, Birmingham B4 6DH, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Zafar","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Medicine, Whittall Street Clinic, Whittall Street, Birmingham B4 6DH, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Shahid","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Medicine, Whittall Street Clinic, Whittall Street, Birmingham B4 6DH, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2010,2,1]]},"reference":[{"key":"bibr-IJSA-09-167C1","unstructured":"Health Protection Agency. All new STI episodes made at genitourinary medicine (GUM) clinics in the United Kingdom: 1998\u20132007. See http:\/\/www.hpa.org.uk\/web\/HPAweb&Page&HPAwebAutoListName\/Page\/1201094610372 (last accessed April 2009)"},{"key":"bibr-IJSA-09-167C2","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-197810000-00005"},{"key":"bibr-IJSA-09-167C3","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-199501000-00007"},{"key":"bibr-IJSA-09-167C4","unstructured":"Clinical Effectiveness Group. BASHH. National Guideline on the Diagnosis and Treatment of Gonorrhoea in Adults 2005. See http:\/\/www.bashh.org\/documents\/116\/116.pdf (last accessed April 2009)"},{"key":"bibr-IJSA-09-167C5","first-page":"491","volume":"49","author":"Bro-Jorgensen A","year":"1973","journal-title":"Br J Vener Dis"},{"key":"bibr-IJSA-09-167C6","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90110-3"},{"key":"bibr-IJSA-09-167C7","unstructured":"Grasp Steering Group. GRASP: The Gonococcal Resistance to Antimicrobials Surveillance Programme. Annual Report 2007. See http:\/\/www.hpa.org.uk\/web\/HPAwebFile\/HPAweb_C\/1221117895841 (last accessed April 2009)"},{"key":"bibr-IJSA-09-167C8","doi-asserted-by":"publisher","DOI":"10.1258\/095646207780658971"},{"key":"bibr-IJSA-09-167C9","doi-asserted-by":"publisher","DOI":"10.1258\/095646207781568556"},{"key":"bibr-IJSA-09-167C10","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/14.suppl_B.295"},{"key":"bibr-IJSA-09-167C11","doi-asserted-by":"publisher","DOI":"10.1258\/0956462052932566"}],"container-title":["International Journal of STD &amp; AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1258\/ijsa.2009.009167","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1258\/ijsa.2009.009167","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1258\/ijsa.2009.009167","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T10:19:42Z","timestamp":1740910782000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1258\/ijsa.2009.009167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["10.1258\/ijsa.2009.009167"],"URL":"https:\/\/doi.org\/10.1258\/ijsa.2009.009167","relation":{},"ISSN":["0956-4624","1758-1052"],"issn-type":[{"value":"0956-4624","type":"print"},{"value":"1758-1052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}